Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients

Yıl: 2019 Cilt: 20 Sayı: 4 Sayfa Aralığı: 224 - 230 Metin Dili: İngilizce DOI: 10.4274/jtgga.galenos.2018.2018.0098 İndeks Tarihi: 11-11-2020

Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients

Öz:
Objective: To evaluate uncommon types of borderline ovarian tumors (BOT) and define the clinical, surgical, and pathologic features.Material and Methods: Seventeen patients who were treated in our hospital between 1990 and 2017 were identified. Patients’ data werecollected from the gynecologic oncology clinic electronic database, patients’ files, and pathology reports. Conservative surgery was defined aspreservation of the uterus and at least part of one ovary.Results: The mean age was 47 (range, 22-70) years. Based on histopathologic tumor type, there was mixed tumor in five (29.4%) patients,endometrioid-type in nine (52.9%), seromusinous-type in two (11.8%), and Brenner-type in one (5.9%). Conservative surgery was performed in4 patients. Two patients with endometrioid BOT had synchronous endometrial pathology, including one (11%) patient with endometrial cancer,one (11%) with endometrial hyperplasia without atypia, and 3 (33%) patients had endometriosis. The median follow-up was 19 (range, 1-137)months. No recurrence was observed during the follow-up period.Conclusion: In our small volume case series, it could be said that non-serous/non-mucinous BOT has excellent prognosis. However, endometrialpathology should be checked in endometrioid type
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: A large population-based study. Gynecol Oncol 2006; 103: 841-7.
  • 2. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch 2017; 470: 125-42.
  • 3. Taylor HC, Malignant and semi-malignant tumours of the ovary. Surg Gynecol Obstet 1929; 48: 204-30.
  • 4. No authors listed. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1-7.
  • 5. Kurman RJ, Carcangiu ML, Herrington CS, Young RHE. WHO classification of tumours of female reproductive organs. IARC: Lyon; 2014.
  • 6. Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 2004; 35: 918-33.
  • 7. Fischerova D, Zikan M, Dundr P, Cibula D. Diagnosis, Treatment, and Follow-Up of Borderline Ovarian Tumors. Oncologist 2012; 17: 1515-33.
  • 8. Ayhan A, Guvendag Guven ES, Guven S, Kucukali T. Recurrence and prognostic factors in borderline ovarian tumors. Gynecol Oncol 2005; 98: 439-45.
  • 9. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of Tumor Pathology. 3rd Series, Fascicle 23. Washington, DC: Armed Forces Institute of Pathology 1998; 1-168.
  • 10. Fauvet R, Poncelet C, Booccara J, Descamps P, Fondrinier E, Darai E. Fertility after conservative treatment for borderline ovarian tumours: a French multicenter study. Fertil Steril 2005; 83: 284-90.
  • 11. Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumours. Fertil Steril 2001; 75: 92-6.
  • 12. du Bois A, Ewald-Riegler N, du Bois O, Harter P. Borderline tumours of the ovary: a systematic review. Geburtshilfe Frauenheilkd 2009; 69: 807-33.
  • 13. Nayyar N, Lakhwani P, Goel A, Pande PK, Kumar K. Management of Borderline Ovarian Tumors-Still a Gray Zone. Indian J Surg Oncol 2017; 8: 607-14.
  • 14. Tempfer CB, Polterauer S, Bentz EK, Reinthaller A, Hefler LA. Accuracy of intraoperative frozen section analysis in borderline tumours of the ovary: a retrospective analysis of 96 cases and review of the literature. Gynecol Oncol 2007; 107: 248-52.
  • 15. Ureyen I, Turan T, Cirik DA, Tasci T, Boran N, Bulbul D, et al. Frozen section in borderline ovarian tumors: Is it reliable? Eur J Obstet Gynecol Reprod Biol 2014; 181: 115-8.
  • 16. Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 2000; 24: 1465-79.
  • 17. Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984; 53: 1156-63.
  • 18. Uzan C, Berretta R, Rolla M, Gouy S, Fauvet R, Darai E, et al. Management and prognosis of endometrioid borderline tumors of the ovary. Surg Oncol 2012; 21: 178-84.
  • 19. Jia SZ, Zhang JJ, Yang JJ, Xiang Y, Liang Z, Leng JH. Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary. J Ovarian Res 2018; 11: 30.
  • 20. Bell DA, Scully RE. Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases. Am J Surg Pathol 1985; 9: 205-14.
  • 21. Snyder RR, Norris HJ, Tavassoli F. Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases. Am J Surg Pathol 1988; 12: 661-71.
  • 22. Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Dovullard P, Darai E, et al. Management and prognosis of borderline ovarian Brenner tumors. Int J Gynecol Cancer 2012; 22: 1332-6.
  • 23. Maeda D, Shih IeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013; 20: 45-52.
  • 24. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol 2004; 28: 1311-8.
  • 25. Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002; 26: 1529-41.
APA Yüksel D, Çakır C, Kimyon Comert G, Kilic C, Durmuş Y, Boran N, Boyraz G, Karalok A, Turan T (2019). Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. , 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
Chicago Yüksel Dilek,Çakır Caner,Kimyon Comert Gunsu,Kilic Cigdem,Durmuş Yasin,Boran Nurettin,Boyraz Gokhan,Karalok Alper,Turan Taner Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. (2019): 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
MLA Yüksel Dilek,Çakır Caner,Kimyon Comert Gunsu,Kilic Cigdem,Durmuş Yasin,Boran Nurettin,Boyraz Gokhan,Karalok Alper,Turan Taner Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. , 2019, ss.224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
AMA Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. . 2019; 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
Vancouver Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. . 2019; 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
IEEE Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T "Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients." , ss.224 - 230, 2019. 10.4274/jtgga.galenos.2018.2018.0098
ISNAD Yüksel, Dilek vd. "Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients". (2019), 224-230. https://doi.org/10.4274/jtgga.galenos.2018.2018.0098
APA Yüksel D, Çakır C, Kimyon Comert G, Kilic C, Durmuş Y, Boran N, Boyraz G, Karalok A, Turan T (2019). Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. Journal of the Turkish-German Gynecological Association, 20(4), 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
Chicago Yüksel Dilek,Çakır Caner,Kimyon Comert Gunsu,Kilic Cigdem,Durmuş Yasin,Boran Nurettin,Boyraz Gokhan,Karalok Alper,Turan Taner Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. Journal of the Turkish-German Gynecological Association 20, no.4 (2019): 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
MLA Yüksel Dilek,Çakır Caner,Kimyon Comert Gunsu,Kilic Cigdem,Durmuş Yasin,Boran Nurettin,Boyraz Gokhan,Karalok Alper,Turan Taner Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. Journal of the Turkish-German Gynecological Association, vol.20, no.4, 2019, ss.224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
AMA Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. Journal of the Turkish-German Gynecological Association. 2019; 20(4): 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
Vancouver Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. Journal of the Turkish-German Gynecological Association. 2019; 20(4): 224 - 230. 10.4274/jtgga.galenos.2018.2018.0098
IEEE Yüksel D,Çakır C,Kimyon Comert G,Kilic C,Durmuş Y,Boran N,Boyraz G,Karalok A,Turan T "Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients." Journal of the Turkish-German Gynecological Association, 20, ss.224 - 230, 2019. 10.4274/jtgga.galenos.2018.2018.0098
ISNAD Yüksel, Dilek vd. "Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients". Journal of the Turkish-German Gynecological Association 20/4 (2019), 224-230. https://doi.org/10.4274/jtgga.galenos.2018.2018.0098